Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Deborah Grady, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address1635 Divisadero Street
    Phone415-514-6717
      Other Positions
      TitleAssociate Dean of Clinical and Translational Research; Co-Director, Clinical and Translational Science Institute


       Overview 
       Overview
      Deborah Grady, MD, MPH is Professor of Epidemiology and Biostatistics and of Medicine, Vice Chair of the Department of Epidemiology and Director of the UCSF/Mount Zion Women's Health Clinical Research Center and the UCSF Women's Health Faculty Development Program.

      Dr. Grady has trained and mentored over 20 young researchers interested in women's health and received the Chancellor's Award for the Advancement of Women in 2000 and the UCSF Mentor of the Year award in 2001. She is an international expert on menopause and the risks and benefits associated with use of postmenopausal hormone therapy.


       ORNG Applications 
       Websites
       In The News
       Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Farhat GN, Parimi N, Chlebowski RT, Manson JE, Anderson G, Huang AJ, Vittinghoff E, Lee JS, Lacroix AZ, Cauley JA, Jackson R, Grady D, Lane DS, Phillips L, Simon MS, Cummings SR. Sex hormone levels and risk of breast cancer with estrogen plus progestin. J Natl Cancer Inst. 2013 Oct 2; 105(19):1496-503.
        View in: PubMed
      2. Daniels LB, Grady D, Mosca L, Collins P, Mitlak BH, Amewou-Atisso MG, Wenger NK, Barrett-Connor E. Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes. 2013 Mar 1; 6(2):164-70.
        View in: PubMed
      3. Katz MH, Grady D, Redberg RF. Undertreatment improves, but overtreatment does not. JAMA Intern Med. 2013 Jan 28; 173(2):93.
        View in: PubMed
      4. Grady D. The flip side of performance measures: limiting overtreatment. Arch Intern Med. 2012 Oct 22; 172(19):1512.
        View in: PubMed
      5. Grady D. Improving quality of care at the end of life. Arch Intern Med. 2012 Aug 13; 172(15):1144.
        View in: PubMed
      6. Padula AM, Pressman AR, Vittinghoff E, Grady D, Neuhaus J, Ackerson L, Rudd P, Avins AL. Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study. Am J Med. 2012 Aug; 125(8):804-10.
        View in: PubMed
      7. Grady D, Redberg RF. A different perspective regarding prostate-specific antigen testing: in reply. Arch Intern Med. 2012 Jul 23; 172(14):1111.
        View in: PubMed
      8. Grady D. I just feel terrible. Arch Intern Med. 2012 Jul 23; 172(14):1108-9.
        View in: PubMed
      9. Grady D. Evidence in clinical practice. Arch Intern Med. 2012 Jul 9; 172(13):982.
        View in: PubMed
      10. Grady D. Another reason to be cautious about imaging: comment on "association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism". Arch Intern Med. 2012 Jan 23; 172(2):161.
        View in: PubMed
      11. White WB, Grady D, Giudice LC, Berry SM, Zborowski J, Snabes MC. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder. Am Heart J. 2012 Jan; 163(1):27-32.
        View in: PubMed
      12. Nasser N, Grady D, Balke CW. Commentary: Improving participant recruitment in clinical and translational research. Acad Med. 2011 Nov; 86(11):1334-5.
        View in: PubMed
      13. Grady D, Berkowitz SA. Why is a good clinical prediction rule so hard to find? Arch Intern Med. 2011 Oct 24; 171(19):1701-2.
        View in: PubMed
      14. Grady D. Reasons for overtreatment: comment on "Too little? Too much? Primary care physicians' views on US health care". Arch Intern Med. 2011 Sep 26; 171(17):1586.
        View in: PubMed
      15. Redberg RF, Katz M, Grady D. Editor's Note--to make the case--evidence is required: comment on "Making the case for selective use of statins in the primary prevention setting". Arch Intern Med. 2011 Sep 26; 171(17):1594.
        View in: PubMed
      16. Grady D. Conservative use of prescription drugs: comment on "Communicating uncertainties about prescription drugs to the public". Arch Intern Med. 2011 Sep 12; 171(16):1470.
        View in: PubMed
      17. Newton KM, Grady D. Soy isoflavones for prevention of menopausal bone loss and vasomotor symptoms: comment on "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms". Arch Intern Med. 2011 Aug 8; 171(15):1369-70.
        View in: PubMed
      18. Grady D. The "top 5" health care activities for which less is more: comment on "The 'top 5' lists in primary care". Arch Intern Med. 2011 Aug 8; 171(15):1390.
        View in: PubMed
      19. Grady D, Berkowitz SA, Katz MH. Opioids for chronic pain. Arch Intern Med. 2011 Sep 12; 171(16):1426-7.
        View in: PubMed
      20. Jacoby VL, Grady D, Wactawski-Wende J, Manson JE, Allison MA, Kuppermann M, Sarto GE, Robbins J, Phillips L, Martin LW, O'Sullivan MJ, Jackson R, Rodabough RJ, Stefanick ML. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. Arch Intern Med. 2011 Apr 25; 171(8):760-8.
        View in: PubMed
      21. Grudzen C, Grady D. Improving care at the end of life. Arch Intern Med. 2011 Jul 11; 171(13):1202.
        View in: PubMed
      22. Gibson R, Grady D. Patient experience of overtreatment. Arch Intern Med. 2011 Jun 27; 171(12):1054.
        View in: PubMed
      23. Lo B, Kelch RP, Grady D. Invited commentary--illuminating physicians' financial relationships with industry. Arch Intern Med. 2011 Mar 28; 171(6):587-9.
        View in: PubMed
      24. Redberg R, Katz M, Grady D. Diagnostic tests: another frontier for less is more: or why talking to your patient is a safe and effective method of reassurance. Arch Intern Med. 2011 Apr 11; 171(7):619.
        View in: PubMed
      25. Wenger NK, Mischke JM, Schroeder R, Schroeder K, Collins P, Grady D, Kornitzer M, Mosca L, Barrett-Connor E. Electrocardiograms of menopausal women with coronary heart disease or at increased risk for its occurrence. Am J Cardiol. 2010 Dec 1; 106(11):1580-7.
        View in: PubMed
      26. Wing RR, West DS, Grady D, Creasman JM, Richter HE, Myers D, Burgio KL, Franklin F, Gorin AA, Vittinghoff E, Macer J, Kusek JW, Subak LL. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol. 2010 Sep; 184(3):1005-10.
        View in: PubMed
      27. Huang AJ, Subak LL, Wing R, West DS, Hernandez AL, Macer J, Grady D. An intensive behavioral weight loss intervention and hot flushes in women. Arch Intern Med. 2010 Jul 12; 170(13):1161-7.
        View in: PubMed
      28. Grady D, Redberg RF. Less is more: how less health care can result in better health. Arch Intern Med. 2010 May 10; 170(9):749-50.
        View in: PubMed
      29. Grady D, Cauley JA, Stock JL, Cox DA, Mitlak BH, Song J, Cummings SR. Effect of Raloxifene on all-cause mortality. Am J Med. 2010 May; 123(5):469.e1-7.
        View in: PubMed
      30. Perez AT, Arun B, Tripathy D, Tagliaferri MA, Shaw HS, Kimmick GG, Cohen I, Shtivelman E, Caygill KA, Grady D, Schactman M, Shapiro CL. A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res Treat. 2010 Feb; 120(1):111-8.
        View in: PubMed
      31. Lo B, Grady D. Strengthening institutional review board review of highly innovative interventions in clinical trials. JAMA. 2009 Dec 23; 302(24):2697-8.
        View in: PubMed
      32. Huang AJ, Luft J, Grady D, Kuppermann M. The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women. J Gen Intern Med. 2010 Jan; 25(1):45-51.
        View in: PubMed
      33. Grady D, Macer J, Kristof M, Shen H, Tagliaferri M, Creasman J. Is a shorter hot flash diary just as good as a 7-day diary? Menopause. 2009 Sep-Oct; 16(5):932-6.
        View in: PubMed
      34. Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause. 2009 Jul-Aug; 16(4):639-43.
        View in: PubMed
      35. Barrett-Connor E, Cox DA, Song J, Mitlak B, Mosca L, Grady D. Raloxifene and risk for stroke based on the framingham stroke risk score. Am J Med. 2009 Aug; 122(8):754-61.
        View in: PubMed
      36. Hulley S, Grady D. Postmenopausal hormone treatment. JAMA. 2009 Jun 17; 301(23):2493-5.
        View in: PubMed
      37. Grady D, Sawaya GF, Johnson KC, Koltun W, Hess R, Vittinghoff E, Kristof M, Tagliaferri M, Cohen I, Ensrud KE. MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause. 2009 May-Jun; 16(3):458-65.
        View in: PubMed
      38. Ensrud KE, Stone KL, Blackwell TL, Sawaya GF, Tagliaferri M, Diem SJ, Grady D. Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause. 2009 Mar-Apr; 16(2):286-92.
        View in: PubMed
      39. Collins P, Mosca L, Geiger MJ, Grady D, Kornitzer M, Amewou-Atisso MG, Effron MB, Dowsett SA, Barrett-Connor E, Wenger NK. Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation. 2009 Feb 24; 119(7):922-30.
        View in: PubMed
      40. Subak LL, Wing R, West DS, Franklin F, Vittinghoff E, Creasman JM, Richter HE, Myers D, Burgio KL, Gorin AA, Macer J, Kusek JW, Grady D. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009 Jan 29; 360(5):481-90.
        View in: PubMed
      41. Jacoby VL, Grady D, Sawaya GF. Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol. 2009 Feb; 200(2):140.e1-9.
        View in: PubMed
      42. Mosca L, Grady D, Barrett-Connor E, Collins P, Wenger N, Abramson BL, Paganini-Hill A, Geiger MJ, Dowsett SA, Amewou-Atisso M, Kornitzer M. Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease. Stroke. 2009 Jan; 40(1):147-55.
        View in: PubMed
      43. Cohen BE, Chang AA, Grady D, Kanaya AM. Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial. Metab Syndr Relat Disord. 2008 Sep; 6(3):223-9.
        View in: PubMed
      44. Grady D, Cauley JA, Geiger MJ, Kornitzer M, Mosca L, Collins P, Wenger NK, Song J, Mershon J, Barrett-Connor E. Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. J Natl Cancer Inst. 2008 Jun 18; 100(12):854-61.
        View in: PubMed
      45. Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flushes in older postmenopausal women. Arch Intern Med. 2008 Apr 28; 168(8):840-6.
        View in: PubMed
      46. Huang A, Yaffe K, Vittinghoff E, Kuppermann M, Addis I, Hanes V, Quan J, Grady D. The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women. Am J Obstet Gynecol. 2008 Mar; 198(3):265.e1-7.
        View in: PubMed
      47. Lo B, Kriegstein A, Grady D. Clinical trials in stem cell transplantation: guidelines for scientific and ethical review. Clin Trials. 2008; 5(5):517-22.
        View in: PubMed
      48. Ensrud KE, Stock JL, Barrett-Connor E, Grady D, Mosca L, Khaw KT, Zhao Q, Agnusdei D, Cauley JA. Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial. J Bone Miner Res. 2008 Jan; 23(1):112-20.
        View in: PubMed
      49. Shepherd R, Macer JL, Grady D. Planning for closeout--from Day One. Contemp Clin Trials. 2008 Mar; 29(2):136-9.
        View in: PubMed
      50. Grady D, Vittinghoff E, Lin F, Hanes V, Ensrud K, Habel LA, Wallace R, Macer J, Cummings SR, Shepherd J. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause. 2007 May-Jun; 14(3 Pt 1):391-6.
        View in: PubMed
      51. Grady D, Barrett-Connor E. Postmenopausal hormone therapy. BMJ. 2007 Apr 28; 334(7599):860-1.
        View in: PubMed
      52. Grady D, Cohen B, Tice J, Kristof M, Olyaie A, Sawaya GF. Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial. Obstet Gynecol. 2007 Apr; 109(4):823-30.
        View in: PubMed
      53. Huang A, Grady D, Blackwell T, Bauer D. Hot flushes, bone mineral density, and fractures in older postmenopausal women. Obstet Gynecol. 2007 Apr; 109(4):841-7.
        View in: PubMed
      54. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol. 2007 Jan 16; 49(2):227-37.
        View in: PubMed
      55. Grady D. Clinical practice. Management of menopausal symptoms. N Engl J Med. 2006 Nov 30; 355(22):2338-47.
        View in: PubMed
      56. Cohen BE, Kanaya AM, Macer JL, Shen H, Chang AA, Grady D. Feasibility and acceptability of restorative yoga for treatment of hot flushes: a pilot trial. Maturitas. 2007 Feb 20; 56(2):198-204.
        View in: PubMed
      57. Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, Chandler W, Settlage J, Beattie MS, Folkerd E, Dowsett M, Grady D, Cummings SR. Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab. 2006 Oct; 91(10):3791-7.
        View in: PubMed
      58. Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, McNabb MA, Wenger NK. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med. 2006 Jul 13; 355(2):125-37.
        View in: PubMed
      59. Yaffe K, Vittinghoff E, Ensrud KE, Johnson KC, Diem S, Hanes V, Grady D. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol. 2006 Jul; 63(7):945-50.
        View in: PubMed
      60. Brown JS, Bradley CS, Subak LL, Richter HE, Kraus SR, Brubaker L, Lin F, Vittinghoff E, Grady D. The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence. Ann Intern Med. 2006 May 16; 144(10):715-23.
        View in: PubMed
      61. Tice JA, Grady D. Alternatives to estrogen for treatment of hot flashes: are they effective and safe? JAMA. 2006 May 3; 295(17):2076-8.
        View in: PubMed
      62. Grady D. Helping women stop postmenopausal hormone therapy. Menopause. 2006 May-Jun; 13(3):323-4.
        View in: PubMed
      63. Subak LL, Brown JS, Kraus SR, Brubaker L, Lin F, Richter HE, Bradley CS, Grady D. The "costs" of urinary incontinence for women. Obstet Gynecol. 2006 Apr; 107(4):908-16.
        View in: PubMed
      64. Diem S, Grady D, Quan J, Vittinghoff E, Wallace R, Hanes V, Ensrud K. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years. Menopause. 2006 Jan-Feb; 13(1):130-8.
        View in: PubMed
      65. Grady D, Sawaya GF. Discontinuation of postmenopausal hormone therapy. Am J Med. 2005 Dec 19; 118 Suppl 12B:163-5.
        View in: PubMed
      66. Steinauer JE, Waetjen LE, Vittinghoff E, Subak LL, Hulley SB, Grady D, Lin F, Brown JS. Postmenopausal hormone therapy: does it cause incontinence? Obstet Gynecol. 2005 Nov; 106(5 Pt 1):940-5.
        View in: PubMed
      67. Waetjen LE, Brown JS, Vittinghoff E, Ensrud KE, Pinkerton J, Wallace R, Macer JL, Grady D. The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women. Obstet Gynecol. 2005 Nov; 106(5 Pt 1):946-52.
        View in: PubMed
      68. Walsh JM, Cheung AM, Yang D, Litwack S, Grady D. Raloxifene and colorectal cancer. J Womens Health (Larchmt). 2005 May; 14(4):299-305.
        View in: PubMed
      69. Yaffe K, Krueger K, Cummings SR, Blackwell T, Henderson VW, Sarkar S, Ensrud K, Grady D. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry. 2005 Apr; 162(4):683-90.
        View in: PubMed
      70. Johnson SR, Ettinger B, Macer JL, Ensrud KE, Quan J, Grady D. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol. Obstet Gynecol. 2005 Apr; 105(4):779-87.
        View in: PubMed
      71. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG. Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease. Am J Cardiol. 2005 Jan 15; 95(2):289-91.
        View in: PubMed
      72. Barrett-Connor E, Grady D, Stefanick ML. The rise and fall of menopausal hormone therapy. Annu Rev Public Health. 2005; 26:115-40.
        View in: PubMed
      73. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Grady D, Shlipak MG. Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol. 2004 Oct 19; 44(8):1593-600.
        View in: PubMed
      74. Grady D, Ettinger B, Moscarelli E, Plouffe L, Sarkar S, Ciaccia A, Cummings S. Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation. Obstet Gynecol. 2004 Oct; 104(4):837-44.
        View in: PubMed
      75. Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Hulley SB, Grady D, Shlipak MG. Predictors of heart failure among women with coronary disease. Circulation. 2004 Sep 14; 110(11):1424-30.
        View in: PubMed
      76. Ettinger B, Ensrud KE, Wallace R, Johnson KC, Cummings SR, Yankov V, Vittinghoff E, Grady D. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol. 2004 Sep; 104(3):443-51.
        View in: PubMed
      77. Hulley SB, Grady D. The WHI estrogen-alone trial--do things look any better? JAMA. 2004 Apr 14; 291(14):1769-71.
        View in: PubMed
      78. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL. Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol. 2004 Mar 3; 43(5):900-21.
        View in: PubMed
      79. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL. Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol. 2004 Mar; 24(3):e29-50.
        View in: PubMed
      80. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabumni RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL. Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women. Arterioscler Thromb Vasc Biol. 2004 Mar; 24(3):394-6.
        View in: PubMed
      81. Mosca L, Appel LJ, Benjamin EJ, Berra K, Chandra-Strobos N, Fabunmi RP, Grady D, Haan CK, Hayes SN, Judelson DR, Keenan NL, McBride P, Oparil S, Ouyang P, Oz MC, Mendelsohn ME, Pasternak RC, Pinn VW, Robertson RM, Schenck-Gustafsson K, Sila CA, Smith SC, Sopko G, Taylor AL, Walsh BW, Wenger NK, Williams CL. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004 Feb 10; 109(5):672-93.
        View in: PubMed
      82. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, Barrett-Connor E. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol. 2003 Dec 15; 158(12):1161-70.
        View in: PubMed
      83. Ettinger B, Grady D, Tosteson AN, Pressman A, Macer JL. Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy. Obstet Gynecol. 2003 Dec; 102(6):1225-32.
        View in: PubMed
      84. Grady D, Ettinger B, Tosteson AN, Pressman A, Macer JL. Predictors of difficulty when discontinuing postmenopausal hormone therapy. Obstet Gynecol. 2003 Dec; 102(6):1233-9.
        View in: PubMed
      85. Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003 Aug 19; 139(4):274-84.
        View in: PubMed
      86. Grady D. Myocardial infarction during menses: lessons from trials and errors. Am J Med. 2003 May; 114(7):611-2.
        View in: PubMed
      87. Grady D, Chaput L, Kristof M. Diagnosis and treatment of coronary heart disease in women: systematic reviews of evidence on selected topics. Evid Rep Technol Assess (Summ). 2003 May; (81):1-4.
        View in: PubMed
      88. Grady D, Chaput L, Kristof M. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Evid Rep Technol Assess (Summ). 2003 May; (80):1-4.
        View in: PubMed
      89. Grady D. Postmenopausal hormones--therapy for symptoms only. N Engl J Med. 2003 May 8; 348(19):1835-7.
        View in: PubMed
      90. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003 Jan 7; 138(1):1-9.
        View in: PubMed
      91. Barnabei VM, Grady D, Stovall DW, Cauley JA, Lin F, Stuenkel CA, Stefanick ML, Pickar JH. Menopausal symptoms in older women and the effects of treatment with hormone therapy. Obstet Gynecol. 2002 Dec; 100(6):1209-18.
        View in: PubMed
      92. Wenger NK, Barrett-Connor E, Collins P, Grady D, Kornitzer M, Mosca L, Sashegyi A, Baygani SK, Anderson PW, Moscarelli E. Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. Am J Cardiol. 2002 Dec 1; 90(11):1204-10.
        View in: PubMed
      93. Grady D, Yaffe K, Kristof M, Lin F, Richards C, Barrett-Connor E. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med. 2002 Nov; 113(7):543-8.
        View in: PubMed
      94. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med. 2002 Aug 12-26; 162(15):1737-45.
        View in: PubMed
      95. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002 Jul 3; 288(1):49-57.
        View in: PubMed
      96. Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA. 2002 Jul 3; 288(1):58-66.
        View in: PubMed
      97. Herrington DM, Vittinghoff E, Howard TD, Major DA, Owen J, Reboussin DM, Bowden D, Bittner V, Simon JA, Grady D, Hulley SB. Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. Arterioscler Thromb Vasc Biol. 2002 Jun 1; 22(6):1012-7.
        View in: PubMed
      98. Grady D. A 60-year-old woman trying to discontinue hormone replacement therapy. JAMA. 2002 Apr 24; 287(16):2130-7.
        View in: PubMed
      99. Yaffe K, Lui LY, Grady D, Stone K, Morin P. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry. 2002 Apr 15; 51(8):677-82.
        View in: PubMed
      100. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol. 2002 Mar; 59(3):378-84.
        View in: PubMed
      101. Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, Rautaharju P, Harper KD. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA. 2002 Feb 20; 287(7):847-57.
        View in: PubMed
      102. Hulley SB, Bittner V, Furberg C, Grady D, Herrington D, Vittinghoff E, Wenger N. Hormone treatment--misconceptions and agreements. Eur Heart J. 2002 Jan; 23(1):89-91.
        View in: PubMed
      103. Shlipak MG, Angeja BG, Go AS, Frederick PD, Canto JG, Grady D. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation. 2001 Nov 6; 104(19):2300-4.
        View in: PubMed
      104. Angeja BG, Shlipak MG, Go AS, Johnston SC, Frederick PD, Canto JG, Barron HV, Grady D. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. J Am Coll Cardiol. 2001 Nov 1; 38(5):1297-301.
        View in: PubMed
      105. Shlipak MG, Simon JA, Grady D, Lin F, Wenger NK, Furberg CD. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol. 2001 Sep; 38(3):705-11.
        View in: PubMed
      106. Mosca L, Barrett-Connor E, Wenger NK, Collins P, Grady D, Kornitzer M, Moscarelli E, Paul S, Wright TJ, Helterbrand JD, Anderson PW. Design and methods of the Raloxifene Use for The Heart (RUTH) study. Am J Cardiol. 2001 Aug 15; 88(4):392-5.
        View in: PubMed
      107. Grady D, Hulley SB. Postmenopausal hormones and heart disease. J Am Coll Cardiol. 2001 Jul; 38(1):8-10.
        View in: PubMed
      108. Nevitt MC, Felson DT, Williams EN, Grady D. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2001 Apr; 44(4):811-8.
        View in: PubMed
      109. Grady D, Hulley SB. Hormones to prevent coronary disease in women: when are observational studies adequate evidence? Ann Intern Med. 2000 Dec 19; 133(12):999-1001.
        View in: PubMed
      110. Hulley SB, Grady D, Browner WS. Statins: underused by those who would benefit. BMJ. 2000 Oct 21; 321(7267):971-2.
        View in: PubMed
      111. Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med. 2000 May 2; 132(9):689-96.
        View in: PubMed
      112. Wenger NK, Grady D. Postmenopausal hormone therapy, SERMs, and coronary heart disease in women. J Endocrinol Invest. 1999 Sep; 22(8):616-24.
        View in: PubMed
      113. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol. 1999 Mar 1; 83(5):660-6.
        View in: PubMed
      114. Barrett-Connor E, Wenger NK, Grady D, Mosca L, Collins P, Kornitzer M, Cox DA, Moscarelli E, Anderson PW. Coronary heart disease in women, randomized clinical trials, HERS and RUTH. Maturitas. 1998 Nov 30; 31(1):1-7.
        View in: PubMed
      115. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998 Aug 19; 280(7):605-13.
        View in: PubMed
      116. Grady D, Applegate W, Bush T, Furberg C, Riggs B, Hulley SB. Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics. Control Clin Trials. 1998 Aug; 19(4):314-35.
        View in: PubMed
      117. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health. 1998; 19:55-72.
        View in: PubMed
      118. Whooley MA, Grady D, Cummings SR. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997 Nov 6; 337(19):1389-90; author reply 1391.
        View in: PubMed
      119. Grady D, Hulley SB, Furberg C. Venous thromboembolic events associated with hormone replacement therapy. JAMA. 1997 Aug 13; 278(6):477.
        View in: PubMed
      120. Grady D, Ernster VL. Hormone replacement therapy and endometrial cancer: are current regimens safe? J Natl Cancer Inst. 1997 Aug 6; 89(15):1088-9.
        View in: PubMed
      121. Lindsay R, Bush TL, Grady D, Speroff L, Lobo RA. Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab. 1996 Nov; 81(11):3829-38.
        View in: PubMed
      122. Walsh JM, Grady D. Treatment of hyperlipidemia in women. JAMA. 1995 Oct 11; 274(14):1152-8.
        View in: PubMed
      123. Walsh MM, Hilton JF, Ernster VL, Masouredis CM, Grady DG. Prevalence, patterns, and correlates of spit tobacco use in a college athlete population. Addict Behav. 1994 Jul-Aug; 19(4):411-27.
        View in: PubMed
      124. Hilton JF, Walsh MM, Masouredis CM, Drues JC, Grady DG, Ernster VL. Planning a spit tobacco cessation intervention: identification of beliefs associated with addiction. Addict Behav. 1994 Jul-Aug; 19(4):381-91.
        View in: PubMed
      125. Hulley SB, Newman TB, Grady D, Garber AM, Baron RB, Browner WS. Should we be measuring blood cholesterol levels in young adults? JAMA. 1993 Mar 17; 269(11):1416-9.
        View in: PubMed
      126. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992 Dec 15; 117(12):1016-37.
        View in: PubMed
      127. Kerlikowske K, Brown JS, Grady DG. Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstet Gynecol. 1992 Oct; 80(4):700-7.
        View in: PubMed
      128. Daniels TE, Hansen LS, Greenspan JS, Grady DG, Hauck WW, Greene JC, Ernster VL. Histopathology of smokeless tobacco lesions in professional baseball players. Associations with different types of tobacco. Oral Surg Oral Med Oral Pathol. 1992 Jun; 73(6):720-5.
        View in: PubMed
      129. Daniels TE, Chou L, Greenspan JS, Grady DG, Hauck WW, Greene JC, Ernster VL. Reduction of Langerhans cells in smokeless tobacco-associated oral mucosal lesions. J Oral Pathol Med. 1992 Mar; 21(3):100-4.
        View in: PubMed
      130. Siegel D, Benowitz N, Ernster VL, Grady DG, Hauck WW. Smokeless tobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am J Public Health. 1992 Mar; 82(3):417-21.
        View in: PubMed
      131. Ernster VL, Grady DG, Greene JC, Walsh M, Robertson P, Daniels TE, Benowitz N, Siegel D, Gerbert B, Hauck WW. Smokeless tobacco use and health effects among baseball players. JAMA. 1990 Jul 11; 264(2):218-24.
        View in: PubMed
      132. Ernster VL, Grady DG, Greene JC. Use of smokeless tobacco in major-league baseball. N Engl J Med. 1988 Oct 13; 319(15):1015.
        View in: PubMed
      133. Siegel D, Grady D, Browner WS, Hulley SB. Risk factor modification after myocardial infarction. Ann Intern Med. 1988 Aug 1; 109(3):213-8.
        View in: PubMed
      Deborah's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP